These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1720845)

  • 1. Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: chemical defibrillation by Ito blockade?
    Tsuchihashi K; Curtis MJ
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):445-56. PubMed ID: 1720845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
    Rees SA; Tsuchihashi K; Hearse DJ; Curtis MJ
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):343-9. PubMed ID: 7504122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart.
    Chi L; Park JL; Friedrichs GS; Banglawala YA; Perez MA; Tanhehco EJ; Lucchesi BR
    Br J Pharmacol; 1996 Mar; 117(6):1261-9. PubMed ID: 8882624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
    Beatch GN; Abraham S; MacLeod BA; Yoshida NR; Walker MJ
    Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tedisamil increases coherence during ventricular fibrillation and decreases defibrillation energy requirements.
    Dorian P; Newman D
    Cardiovasc Res; 1997 Feb; 33(2):485-94. PubMed ID: 9074714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo.
    Bril A; Landais L; Gout B
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):233-40. PubMed ID: 8357777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate.
    Rees SA; Curtis MJ
    Circulation; 1993 Jun; 87(6):1979-89. PubMed ID: 8504513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
    Dukes ID; Cleemann L; Morad M
    J Pharmacol Exp Ther; 1990 Aug; 254(2):560-9. PubMed ID: 2384886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of atrial fibrillation by the experimental antiarrhythmic drug tedisamil in two canine models.
    Fischbach PS; Barrett TD; Goyal R; Tran BC; Syed ZA; Hennan JK; Lucchesi BR
    J Cardiovasc Electrophysiol; 2001 Oct; 12(10):1138-44. PubMed ID: 11699522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
    Bargheer K; Bode F; Klein HU; Trappe HJ; Franz MR; Lichtlen PR
    Eur Heart J; 1994 Oct; 15(10):1409-14. PubMed ID: 7821321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
    Mitrovic V; Oehm E; Thormann J; Pitschner H; Hamm C
    Herz; 2000 Mar; 25(2):130-42. PubMed ID: 10829253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tedisamil and lidocaine enhance each other's antiarrhythmic activity against ischaemia-induced arrhythmias in rats.
    Sarraf G; Barrett TD; Walker MJ
    Br J Pharmacol; 2003 Aug; 139(8):1389-98. PubMed ID: 12922925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
    Barrett TD; Hennan JK; Fischbach PS; O'Neill BP; Driscoll EM; Lucchesi BR
    Br J Pharmacol; 2001 Apr; 132(7):1493-500. PubMed ID: 11264243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tedisamil (Solvay).
    Flores NA
    Curr Opin Investig Drugs; 2001 Jan; 2(1):97-103. PubMed ID: 11527020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is the bradycardic effect of tedisamil at the expense of the loss of the inotropic effect? A pressure-volume analysis with the conductance (volume) catheter technique in patients with coronary artery disease].
    Thormann J; Mitrovic V; Strasser R; Pitschner HF; Riedel H; Bahavar H; Schlepper M
    Z Kardiol; 1993 Apr; 82(4):211-21. PubMed ID: 8506715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
    Wallace AA; Stupienski RF; Baskin EP; Appleby SD; Kothstein T; Gehret JR; King SW; Remy DC; Lynch JJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tedisamil (KC 8857) is a new specific bradycardic drug: does it also influence myocardial contractility? Analysis by the conductance (volume) technique in coronary artery disease.
    Thormann J; Mitrovic V; Riedel H; Neuzner J; Strasser R; Bahavar H; Schlepper M
    Am Heart J; 1993 May; 125(5 Pt 1):1233-46. PubMed ID: 8480574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical defibrillation in acute myocardial ischaemia: a hypothesis.
    Curtis MJ
    J Basic Clin Physiol Pharmacol; 1994; 5(1):1-17. PubMed ID: 8736067
    [No Abstract]   [Full Text] [Related]  

  • 19. Tedisamil in a chronic canine model of atrial flutter.
    Fischbach PS; Johnston PV; Friedrichs GS; Lucchesi BR
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):212-8. PubMed ID: 10445672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tedisamil: master switch of nature?
    Doggrell SA
    Expert Opin Investig Drugs; 2001 Jan; 10(1):129-38. PubMed ID: 11116286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.